Why ZBIO? Zenas BioPharma, Inc. Analysis, Price & AI Insights | Whystock
ZBIO
$19.36+0.04 (+0.21%)
Market ClosedLast close May 1
Zenas BioPharma, Inc., a clinical-stage biopharma company, engages in the development and commercialization of transformative immunology-based therapies.